<DOC>
	<DOC>NCT03024671</DOC>
	<brief_summary>The dermatological testing of cosmetic products which are new on the market, or existing products with novel formulations is common and a useful procedure, yet necessary to alleviate common irritants and contact allergic reactions. Cosmetic products contain a range of substances that may be considered as potential irritants or contact allergens. In order to estimate that risk, cosmetics are tested by applying patch tests.</brief_summary>
	<brief_title>Epicutaneous Testing of Cosmetics</brief_title>
	<detailed_description>The dermatological testing of cosmetic products which are new on the market, or existing products with novel formulations is common and a useful procedure, yet necessary to alleviate common irritants and contact allergic reactions. Cosmetic products contain a range of substances that may be considered as potential irritants or contact allergens. In order to estimate that risk, cosmetics are tested by applying patch tests, as with allergic reactions.</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<criteria>Men and women older than 18 years old Persons undergoing a diagnostic patch test for reason of a skin disease Signed written informed consent Acute skin inflammation and eczema on the back Systemic corticosteroid and immunosuppressive therapy as well as UV exposure of the back within the last 4 weeks Topical corticosteroids used on the back within the last two weeks</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>